Last update 27 May 2025

Compound 19e(Cardiff University )

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
STS x aromatase
Action
inhibitors
Mechanism
STS inhibitors(Steryl-sulfatase inhibitors), aromatase inhibitors(Aromatase inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Estrogen receptor positive breast cancer
Inactive Indication-
Originator Organization
Zagazig UniversityZagazig UniversityAl-Ain University of Science & TechnologyAl-Ain University of Science & TechnologyUniversity of CardiffUniversity of Cardiff
Active Organization
University of CardiffUniversity of CardiffAl-Ain University of Science & TechnologyAl-Ain University of Science & TechnologyZagazig UniversityZagazig University
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Compound 19e(Cardiff University )
Login to view more data
100 Translational Medicine associated with Compound 19e(Cardiff University )
Login to view more data
100 Patents (Medical) associated with Compound 19e(Cardiff University )
Login to view more data
1
Literatures (Medical) associated with Compound 19e(Cardiff University )
RSC Medicinal Chemistry
Development of benzofuran-derived sulfamates as dual aromatase-steroid sulfatase inhibitors (DASIs): design, synthesis and biological evaluation
100 Deals associated with Compound 19e(Cardiff University )
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Estrogen receptor positive breast cancerPreclinical
Egypt
Zagazig UniversityZagazig University
01 Jan 2025
Estrogen receptor positive breast cancerPreclinical
United Arab Emirates
Al-Ain University of Science & TechnologyAl-Ain University of Science & Technology
01 Jan 2025
Estrogen receptor positive breast cancerPreclinical
United Kingdom
University of CardiffUniversity of Cardiff
01 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free